Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Bowling Green › NPI 1790751253
Supplier

Wood County Hospital Assn

Wood County Hospital Assn was paid $13.28M by Medicaid between Jan 2018 and Dec 2024, across 252 billing codes. Its largest line is 99283, emergency room visit (moderate) — 15% of everything it billed.

33Billing provider infoWOOD COUNTY HOSPITAL ASSN
BOWLING GREEN, OH 43402
33aNPI1790751253assigned 02/24/2006
33bProvider typePharmacy
28Total paid$13.28M
24GClaims434,304
24DCodes billed252
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Pharmacy providers in Ohio

Rank by total paid#2 of 47
Median peer was paid$489.48
This provider vs. median27,139×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201845,183$1.15M
201936,936$941K
202031,017$1.10M
202138,277$1.45M
202239,738$1.42M
2023146,526$4.28M
2024incomplete96,627$2.94M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 15% 18,370 16,461 $2.03M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 15% 16,116 14,178 $2.02M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 8.6% 5,526 4,280 $1.15M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.5% 5,776 5,006 $736K
96361 Intravenous infusion, hydration; each additional hour 5.3% 2,302 1,512 $701K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 4.5% 8,479 2,912 $598K
74177 Computed tomography, abdomen and pelvis; with contrast material 4.1% 2,120 1,686 $543K
97530 Therapeutic activities, direct patient contact, each 15 minutes 3.5% 5,512 1,806 $462K
70450 Computed tomography, head or brain; without contrast material 3.1% 1,791 1,452 $416K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.5% 4,916 1,308 $338K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 2.3% 2,895 2,654 $312K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.0% 2,321 2,024 $270K
240 more codes
97803 1.6% 2,433 $212K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.6% 1,997 $207K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1.3% 4,518 $177K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.1% 732 $144K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.0% 572 $134K
64483 <1% 205 $128K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 1,060 $114K
G0378 Hospital observation service, per hour <1% 1,816 $109K
80053 Comprehensive metabolic panel <1% 5,928 $107K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,863 $101K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 892 $92K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,777 $65K
74246 <1% 426 $64K
80048 Basic metabolic panel (calcium, ionized) <1% 15,289 $62K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,976 $61K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 27,764 $60K
97161 <1% 864 $58K
71046 Radiologic examination, chest; 2 views <1% 3,198 $57K
71275 Computed tomographic angiography, chest, with contrast material <1% 274 $54K
84443 Thyroid stimulating hormone (TSH) <1% 3,989 $53K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 531 $50K
36415 Collection of venous blood by venipuncture <1% 23,875 $48K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 243 $46K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 465 $45K
87086 Culture, bacterial; quantitative colony count, urine <1% 5,045 $44K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 204 $43K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 823 $41K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 51 $38K
84439 <1% 2,300 $38K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 4,909 $34K
80076 <1% 7,939 $33K
80061 Lipid panel <1% 3,098 $32K
82607 <1% 1,716 $32K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 2,475 $31K
87070 <1% 1,509 $30K
S9445 Patient education, not otherwise classified, non-physician provider, individual, per session <1% 1,002 $29K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 713 $29K
97802 <1% 335 $29K
81513 <1% 239 $28K
99213 Doctor's office visit, returning patient (routine) <1% 282 $28K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,459 $28K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,370 $26K
82553 <1% 5,527 $23K
82728 <1% 1,188 $23K
88142 <1% 1,104 $23K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 194 $23K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 76 $21K
83036 Hemoglobin; glycosylated (A1C) <1% 1,804 $21K
81001 <1% 14,502 $19K
74018 <1% 483 $19K
84484 <1% 7,616 $19K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 781 $19K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 9,630 $18K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 894 $18K
96367 <1% 432 $17K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 226 $17K
77063 Screening digital breast tomosynthesis, bilateral <1% 383 $15K
83874 <1% 5,766 $14K
87480 <1% 917 $14K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 2,241 $14K
84702 <1% 657 $14K
72100 <1% 534 $13K
73562 <1% 553 $13K
71045 Radiologic examination, chest; single view <1% 5,005 $12K
83970 <1% 736 $12K
86850 <1% 494 $12K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 695 $11K
83540 <1% 1,027 $11K
73630 <1% 588 $11K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 112 $11K
73610 <1% 484 $10K
84481 <1% 782 $10K
87077 <1% 1,191 $10K
J3490 Unclassified drugs <1% 3,073 $10K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 982 $9K
86592 <1% 334 $9K
87660 <1% 843 $9K
84425 <1% 1,057 $9K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 66 $9K
82746 <1% 856 $9K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 508 $8K
87510 <1% 915 $8K
73030 <1% 349 $8K
64493 <1% 15 $8K
86140 <1% 562 $8K
73130 <1% 459 $8K
71250 <1% 77 $8K
0002A <1% 202 $8K
82570 <1% 991 $8K
86900 <1% 542 $7K
97165 <1% 74 $7K
0001A <1% 206 $7K
94060 <1% 56 $7K
86803 <1% 577 $7K
72125 Computed tomography, cervical spine; without contrast material <1% 492 $7K
83735 <1% 2,601 $7K
86787 <1% 199 $6K
85027 <1% 719 $6K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 7,489 $5K
87186 <1% 1,187 $5K
87481 <1% 239 $5K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 321 $5K
77067 Screening mammography, bilateral, including computer-aided detection <1% 383 $5K
87147 <1% 611 $5K
84466 <1% 507 $5K
73110 <1% 236 $5K
87653 <1% 104 $4K
83013 <1% 104 $4K
92523 <1% 50 $4K
97035 <1% 67 $4K
80081 <1% 119 $4K
83690 <1% 7,346 $4K
97113 <1% 45 $3K
97010 <1% 119 $3K
82043 <1% 747 $3K
84703 <1% 5,929 $3K
85610 <1% 1,928 $3K
83550 <1% 344 $3K
84153 <1% 206 $3K
86901 <1% 542 $3K
84403 <1% 148 $3K
83525 <1% 108 $3K
96375 Therapeutic injection; each additional sequential IV push <1% 8,897 $3K
84100 <1% 528 $3K
82950 <1% 203 $3K
87081 <1% 341 $3K
72040 <1% 90 $3K
82947 <1% 3,827 $3K
85652 <1% 572 $2K
82550 <1% 5,828 $2K
94729 <1% 31 $2K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 21 $2K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 24 $2K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 1,112 $2K
87505 <1% 20 $2K
82565 <1% 3,907 $2K
83001 <1% 79 $2K
73502 <1% 110 $2K
64615 <1% 38 $2K
83880 <1% 695 $2K
87486 <1% 1,061 $2K
93971 <1% 17 $2K
80051 <1% 3,627 $2K
86038 <1% 76 $2K
84146 <1% 86 $1K
94726 <1% 20 $1K
S9446 Patient education, not otherwise classified, non-physician provider, group, per session <1% 25 $1K
J7030 Infusion, normal saline solution , 1000 cc <1% 11,035 $1K
20552 <1% 13 $1K
87581 <1% 1,063 $1K
82948 <1% 1,506 $1K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,288 $1K
77080 <1% 13 $1K
96376 <1% 1,268 $1K
83605 <1% 1,179 $1K
82150 <1% 1,217 $1K
85730 <1% 1,441 $985.73
87205 <1% 259 $864.57
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 57 $807.99
72110 <1% 30 $803.10
87340 <1% 71 $779.45
83014 <1% 104 $756.73
84520 <1% 3,791 $751.36
85379 <1% 1,185 $733.89
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,298 $711.20
84156 <1% 170 $711.06
82077 <1% 627 $676.02
87040 <1% 477 $657.32
87109 <1% 24 $650.34
83615 <1% 141 $645.56
73080 <1% 33 $592.73
87088 <1% 308 $579.13
80349 <1% 68 $556.12
82248 <1% 54 $543.52
84550 <1% 75 $502.18
80143 <1% 449 $492.17
Q3014 Telehealth originating site facility fee <1% 26 $461.42
J1170 Injection, hydromorphone, up to 4 mg <1% 1,011 $412.44
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,994 $406.06
82670 <1% 12 $397.73
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,027 $382.77
90715 <1% 23 $370.29
86696 <1% 15 $346.64
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 1,113 $346.23
84436 <1% 31 $339.83
J7050 Infusion, normal saline solution, 250 cc <1% 2,577 $320.56
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,805 $319.75
83002 <1% 13 $252.43
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 118 $232.83
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,323 $225.97
86481 <1% 12 $207.54
86706 <1% 13 $167.95
80179 <1% 419 $166.94
74022 <1% 32 $163.47
J1040 Injection, methylprednisolone acetate, 80 mg <1% 930 $106.80
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 815 $102.68
J1815 Injection, insulin, per 5 units <1% 125 $100.40
80321 <1% 53 $97.96
84145 <1% 89 $96.58
J2704 Injection, propofol, 10 mg <1% 1,986 $80.41
94761 <1% 2,552 $67.83
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,606 $66.57
C9113 Injection, pantoprazole sodium, per vial <1% 80 $64.51
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,826 $48.10
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 537 $38.63
J7999 Compounded drug, not otherwise classified <1% 34 $36.33
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 175 $32.10
82803 <1% 13 $28.11
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 280 $28.08
84450 <1% 33 $26.90
J0690 Injection, cefazolin sodium, 500 mg <1% 778 $26.43
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 110 $21.00
J1630 Injection, haloperidol, up to 5 mg <1% 87 $18.01
84460 <1% 33 $17.94
J1644 Injection, heparin sodium, per 1000 units <1% 82 $15.87
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,694 $13.91
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 293 $10.57
J1030 Injection, methylprednisolone acetate, 40 mg <1% 129 $8.72
J2470 Injection, pantoprazole sodium, 40 mg <1% 31 $7.72
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 102 $7.20
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 370 $4.75
91300 <1% 390 $3.84
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 100 $3.15
J1650 Injection, enoxaparin sodium, 10 mg <1% 23 $3.13
J2060 Injection, lorazepam, 2 mg <1% 58 $2.09
J1171 Injection, hydromorphone, 0.1 mg <1% 38 $1.51
J2550 Injection, promethazine hcl, up to 50 mg <1% 41 $1.20
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 43 $1.19
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 17 $0.55
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 16 $0.22
00170 Anesthesia for intraoral procedures, including biopsy 0% 33 $0.00
82310 0% 25 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 348 $0.00
J2253 Injection, midazolam (seizalam), 1 mg 0% 49 $0.00
97150 Therapeutic procedure(s), group (2 or more individuals) 0% 45 $0.00
94760 0% 487 $0.00
88304 0% 23 $0.00
87807 0% 29 $0.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 0% 23 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 94 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBORTEL, KAROL (CFO)